Literature DB >> 5422023

Lipolysis and lipogenesis from glucose in human fat cells of different sizes. Effects of insulin, epinephrine, and theophylline.

R B Goldrick, G M McLoughlin.   

Abstract

Lipogenesis from glucose and lipolysis in human omental and subcutaneous fat cells were studied as functions of adipose cell size and number in adult females. Since subcutaneous fat cells were larger than those prepared from the greater omentum, a comparison could be made of the metabolism of different sizes of cells within individual subjects. Rates per cell of glyceride-glycerol and glyceride-fatty acid synthesis from glucose were similar in omental and subcutaneous fat cells incubated in the presence or absence of insulin. However, subcutaneous fat cells exhibited higher rates of basal lipolysis than omental fat cells and these differences were maintained when lipolysis was stimulated with theophylline. Different rates of lipolysis were not demonstrable after incubations with epinephrine, indicating that subcutaneous fat cells were less responsive to this hormone than smaller omental fat cells. Correlation and partial correlation analysis showed that differences in basal and theophylline-stimulated lipolysis between fat cells prepared from different subjects and between omental and subcutaneous fat cells could be accounted for by differences in adipose cell volume. In subcutaneous fat cells highly significant intercorrelations were demonstrated between cell volume, basal lipolysis, and the basal conversion of glucose to glyceride-glycerol. There was no correlation between fat cell volume, age, or relative obesity and the effects of theophylline or insulin on lipolysis or lipogenesis from glucose in vitro when the data were expressed as percentage changes above basal values.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5422023      PMCID: PMC322587          DOI: 10.1172/JCI106335

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  FATTY-ACID METABOLISM BY HUMAN ADIPOSE TISSUES.

Authors:  M HAMOSH; P HAMOSH; J A BAR-MAOR; H COHEN
Journal:  J Clin Invest       Date:  1963-10       Impact factor: 14.808

2.  A PROCEDURE FOR IN VITRO STUDIES ON FATTY ACID METABOLISM BY HUMAN SUBCUTANEOUS ADIPOSE TISSUE.

Authors:  J OSTMAN
Journal:  Acta Med Scand       Date:  1965-02

3.  Body fat, blood pressure and serum cholesterol of Australian men.

Authors:  H M WHYTE; I A GRAHAM; M S DE WOLFE
Journal:  Australas Ann Med       Date:  1958-11

4.  Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline.

Authors:  L A Carlson; D Hallberg; H Micheli
Journal:  Acta Med Scand       Date:  1969-06

5.  Action of adipokinetic hormones on human adipose tissue in vitro.

Authors:  B Mosinger; E Kuhn; V Kujalová
Journal:  J Lab Clin Med       Date:  1965-09

6.  The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity.

Authors:  L B Salans; J L Knittle; J Hirsch
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

7.  Effects of prolonged incubation and cell concentration on lipogenesis from glucose in isolated human omental fat cells.

Authors:  R B Goldrick; B C Ashley; M L Lloyd
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

8.  Hormonal regulation of lipolysis and phosphorylase activity in human fat cells.

Authors:  J Moskowitz; J N Fain
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

9.  Effects of insulin on glucose metabolism in isolated human fat cells.

Authors:  R B Goldrick
Journal:  J Lipid Res       Date:  1967-11       Impact factor: 5.922

10.  Methods for the determination of adipose cell size in man and animals.

Authors:  J Hirsch; E Gallian
Journal:  J Lipid Res       Date:  1968-01       Impact factor: 5.922

View more
  28 in total

1.  Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities.

Authors:  M B Davidson; R T Young
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

2.  Abdominal subcutaneous adipose tissue cellularity in men and women.

Authors:  D P Andersson; E Arner; D E Hogling; M Rydén; P Arner
Journal:  Int J Obes (Lond)       Date:  2017-06-20       Impact factor: 5.095

3.  Relationship between anthropometric indices of body fat distribution and basal energy metabolism in healthy Maltese women.

Authors:  E Pullicino; C Copperstone; L Luzi; G McNeill; M Elia
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

4.  Cellular basis of insulin insensitivity in large rat adipocytes.

Authors:  M P Czech
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

5.  Adipocyte fatty acid mobilization in vivo: effects of age and anatomical location.

Authors:  A D Hartman
Journal:  Lipids       Date:  1985-05       Impact factor: 1.880

Review 6.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

7.  Relationship between body fat mass and free fatty acid kinetics in men and women.

Authors:  Bettina Mittendorfer; Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2009-07-23       Impact factor: 5.002

8.  Multiple symmetric lipomatosis: a defect in adrenergic-stimulated lipolysis.

Authors:  G Enzi; E M Inelmen; A Baritussio; P Dorigo; M Prosdocimi; F Mazzoleni
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

9.  Enhanced activity of hormone-sensitive adenylate cyclase during dietary restriction in the rat: dependence on age and relation to cell size.

Authors:  B Cooper; F Weinblatt; R I Gregerman
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

10.  The 6th Annual World Congress on the insulin resistance syndrome.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.